Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-09 5:18 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Partners L.P. | 3,961,602 7.1% | 3,961,602 (New Position) | View |
| 2023-11-07 5:04 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners L.P. | 1,000,000 2.5% | 0 (Unchanged) | View |
| 2023-10-16 4:45 pm Purchase | 13G | ARAMARK ARMK | Farallon Capital Partners L.P. | 15,381,069 5.9% | 4,552,185 (+42.04%) | View |
| 2023-09-22 5:05 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners L.P. | 1,000,000 2.5% | 0 (Unchanged) | View |
| 2023-09-22 3:20 pm Purchase | 13G | BEAM THERAPEUTICS INC BEAM | Farallon Capital Partners L.P. | 4,113,469 5.2% | 713,548 (+20.99%) | View |
| 2023-08-11 5:17 pm Purchase | 13D | CHINOOK THERAPEUTICS INC KDNY | Farallon Capital Partners L.P. | 7,110,000 9.9% | 7,110,000 (New Position) | View |
| 2023-08-10 3:57 pm Purchase | 13G | FORTE BIOSCIENCES FBRX | Farallon Capital Partners L.P. | 3,787,636 9.9% | 3,787,636 (New Position) | View |
| 2023-06-16 5:21 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners L.P. | 1,000,000 2.6% | 0 (Unchanged) | View |
| 2023-06-02 4:59 pm Purchase | 13D | EXELIXIS INC EXEL | Farallon Capital Partners L.P. | 25,860,000 7.9% | 2,394,000 (+10.20%) | View |
| 2023-05-16 5:25 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners L.P. | 1,000,000 2.6% | 0 (Unchanged) | View |
| 2023-04-27 5:28 pm Unchanged | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners L.P. | 1,000,000 2.6% | 0 (Unchanged) | View |
| 2023-04-06 8:54 pm Unchanged | 13D | EXELIXIS INC EXEL | Farallon Capital Partners L.P. | 23,466,000 7.2% | 0 (Unchanged) | View |
| 2023-04-06 4:58 pm Purchase | 13G | FOREST RD ACQUISITION CORP II FRXB | Farallon Capital Partners L.P. | 400,000 8.9% | 400,000 (New Position) | View |
| 2023-03-27 4:33 pm Unchanged | 13D | EXELIXIS INC EXEL | Farallon Capital Partners L.P. | 23,466,000 7.2% | 0 (Unchanged) | View |
| 2023-03-24 1:34 pm Purchase | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners L.P. | 1,000,000 2.5% | 1,000,000 (New Position) | View |
| 2023-03-20 4:39 pm Purchase | 13D | EXELIXIS INC EXEL | Farallon Capital Partners L.P. | 23,466,000 7.2% | 23,466,000 (New Position) | View |
| 2023-02-17 3:20 pm Purchase | 13G | AVROBIO INC AVRO | Farallon Capital Partners L.P. | 3,116,000 7.1% | 3,116,000 (New Position) | View |
| 2023-02-14 08:27 am Sale | 13G | BEAM THERAPEUTICS INC BEAM | Farallon Capital Partners L.P. | 3,399,921 4.8% | -151,850 (-4.28%) | View |
| 2023-02-09 4:55 pm Unchanged | 13G | SHELTER ACQUISITION CORP I CL SHQA | Farallon Capital Partners L.P. | 0 0% | 0 (Unchanged) | View |
| 2023-02-09 4:55 pm Purchase | 13G | SWIFTMERGE ACQUISITION CORP CL IVCP | Farallon Capital Partners L.P. | 2,205,000 9.7% | 2,205,000 (New Position) | View |